Menu

Logo
Torreya Partners

M&A Advisory Firm

New York, New York HQ

Member since
2011
Deals they've closed
29
About
Torreya Partners is a boutique advisory firm focused on healthcare and the life sciences and was formed in January 2008. We have offices in New York, Philadelphia and San Francisco. Our goal is to create a collegial, user-friendly firm that provides the life science community with first-quality advi…
Team (5)
Recent Transactions (29)
Torreya Partners
Real estate asset management services (except property management), Securities, Commodity Contracts, and Other Financial Investments and Related Activities, Trust, Fiduciary, and Custody Activities
Advised

Topix Pharmaceuticals

in securing investment from

New Mountain Capital LLC

June 2016

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Cardiome Pharma Corp.

in securing investment from

Allergan, Plc

April 2016

Torreya Partners
Pharmaceutical and Medicine Manufacturing, Research and Development in Biotechnology
Advised

The Female Health Company

in their acquisition by

Aspen Park Pharmaceuticals, Inc

April 2016

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Acerus Pharmaceuticals Corporation

in securing investment from

Aytu BioScience, Inc

March 2016

Torreya Partners
Medical Equipment and Supplies Manufacturing, Medical glassware made from purchased glass, Medical glassware made in glass making plants, Pharmaceutical and Medicine Manufacturing
Advised

Eisai Inc.

in their acquisition by

PBM Capital Group

March 2016

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Private Spec Pharma

in securing investment from

Undisclosed

February 2016

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Cambrooke Therapeutics

in securing investment from

Undisclosed

January 2016

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Amerigen Pharmaceuticals Inc

in securing investment from

Undisclosed

December 2015

Torreya Partners
Research and Development in Biotechnology
Advised

PhosImmune Inc.

in their acquisition by

Agenus Inc

December 2015

Torreya Partners
Health Care Services, Pharmaceutical and Medicine Manufacturing
Advised

Dara Biosciences Inc

in their acquisition by

Midatech Pharma

November 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Mimetogen Pharmaceuticals Inc

in securing investment from

Allergan, Plc

October 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

XOMA Ltd.

in securing investment from

Novartis

October 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

IGI Laboratories, Inc

in their acquisition by

Alveda Pharmaceuticals Inc

October 2015

Torreya Partners
Healthcare Software (Consumer), Healthcare Software (Enterprise)
Advised

Crown Laboratories

in securing debt financing from

Hayfin Capital

September 2015

Torreya Partners
Health Care Services, Pharmaceutical and Medicine Manufacturing
Advised

Crown Laboratories, Inc

in securing debt financing from

Hayfin Capital Management LLP

September 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

OctreoPharm

in their acquisition by

Ipsen

July 2015

Torreya Partners
Research and Development in Biotechnology
Advised

cCAM

in their acquisition by

Merck

July 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Teva Pharmaceutical Industries

in securing investment from

ANI Pharmaceuticals, Inc

June 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Ipsen Innovation for patient care

in their acquisition by

OctreoPharma Sciences

May 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

arGen-X

in securing investment from

Leo Pharmaceuticals

April 2015

Torreya Partners
Research and Development in Biotechnology
Advised

Phenex Pharmaceuticals AG

in securing investment from

Gilead Sciences, Inc.

January 2015

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Rimsa

in their acquisition by

Teva Pharmaceutical Industries

January 2015

Torreya Partners
Health Care Services, Pharmaceutical and Medicine Manufacturing
Advised

PDI, Inc.

in securing debt financing from

Undisclosed

October 2014

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

RedPath Integrated Pathology

in their acquisition by

PDI, Inc.

October 2014

Torreya Partners
Health Care Services, Medical Equipment and Supplies Manufacturing, Medical glassware made from purchased glass, Medical glassware made in glass making plants
Advised

Innovative Therapies

in their acquisition by

Cardinal Health, Inc. (NYSE:CAH)

September 2014

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Fibrotech Theraputics

in their acquisition by

Shire Plc

July 2014

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Trimel Pharmaceuticals Corporation

in securing investment from

Undisclosed

July 2014

Torreya Partners
Research and Development in Biotechnology
Advised

Compugen

in securing investment from

Undisclosed

January 2014

Torreya Partners
Pharmaceutical and Medicine Manufacturing
Advised

Correvio International

in their acquisition by

Cardiome Pharma Corp.

November 2013

Sectors Torreya Partners serves:
Health Care
Life Sciences

Join Axial's Private M&A Platform

Torreya Partners connects with qualified M&A advisors through the Axial Platform.

Selling Your Company?

Find the perfect advisor to help you sell your business.

Find Deals

Grow your deal flow without more headcount.

Member since
2011
Deals they've closed
29
Team (5)
Join as Owner Join as Investor